Is cetirizine (antihistamine) safe for patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cetirizine Safety in G6PD Deficiency

Cetirizine is safe to use in patients with G6PD deficiency at standard therapeutic doses, as antihistamines are not among the medications that cause hemolysis in this population.

Evidence-Based Medication Classification

The most comprehensive and recent evidence establishes that only seven medications are definitively contraindicated in G6PD deficiency 1, 2, 3, 4:

  • Dapsone 1, 2
  • Methylthioninium chloride (methylene blue) 1, 2
  • Primaquine 1, 2
  • Rasburicase 1, 2
  • Nitrofurantoin 3
  • Phenazopyridine 3
  • Tolonium chloride (toluidine blue) 3

Cetirizine does not appear on any contraindicated or cautionary medication lists for G6PD deficiency 1, 2, 3, 4.

Real-World Safety Data

A large-scale real-world study of 31,962 G6PD-deficient patients found that only 71 cases (0.2%) experienced major hemolysis requiring hospitalization over a 13-year period 5. Of these cases:

  • 71.8% were caused by fava bean ingestion 5
  • 8.5% were associated with infections 5
  • Only 4.2% (3 cases) were potentially medication-related, involving nitrofurantoin, phenazopyridine, and an unspecified "pain killer" 5

This study demonstrated that hundreds to thousands of G6PD-deficient patients safely received medications previously suspected of causing hemolysis, providing reassurance that the actual risk from most medications is extremely low 5.

Clinical Implications for Antihistamine Use

Antihistamines like cetirizine have never been documented to cause hemolytic crises in G6PD-deficient patients 3, 4. The systematic literature review that established the seven definitively contraindicated medications found no evidence contraindicating antihistamine use in normal therapeutic doses 3.

Important Monitoring Considerations

While cetirizine is safe, when starting any new medication in G6PD-deficient patients, monitor for signs of hemolysis 1:

  • Jaundice 1, 6
  • Dark urine 1
  • Fatigue 1
  • Pallor 1

Common Pitfall to Avoid

Many medications have been wrongly cited as causing hemolysis because they were administered during infection-related hemolytic episodes, leading to confusion about which drugs are truly dangerous 3. The evidence shows that cetirizine and other antihistamines can be prescribed without concern for G6PD status 3, 4.

References

Guideline

Miralax Safety in G6PD Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medications Contraindicated in G6PD Deficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of G6PD Deficiency in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.